Royal Bank Of Canada Applied Genetic Technologies Corp Transaction History

Royal Bank Of Canada

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.29 - $0.89 $112 - $345	388 New	388 $0
Q2 2022 Aug 15, 2022	SELL	$0.62 - $1.1 $18 - $33	-30 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.07 - $2.71 $2,772 - $7,021	-2,591 Reduced 98.86%	30 $0
Q4 2021 Feb 14, 2022	BUY	$1.87 - $2.91 $4,901 - $7,627	2,621 New	2,621 $5,000
Q3 2021 Nov 15, 2021	SELL	$3.01 - $4.12 $48,677 - $66,628	-16,172 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.62 - $5.23 $58,542 - $84,579	16,172 New	16,172 $63,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.